Onchilles Pharma Appoints Dr. Lev Becker As Chief Scientific Officer and Emily Roberts Thomson As Senior Vice President of Development Operations
Jan 13, 2025•11 months ago
Position
Vice President
Company
Onchilles Pharma
Description
Onchilles Pharma has announced the appointment of Dr. Lev Becker as Chief Scientific Officer and Emily Roberts-Thomson as Senior Vice President of Development Operations. Dr Becker led the groundbreaking discovery of the ELANE pathway and will focus on advancing the company’s pipeline, while Emily Roberts-Thomson brings over 23 years of global clinical development and operational expertise to the team.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months